Global MS market to reach $19.5 billion in 2017, report finds
FARMINGTON, Conn. – The global market for treatments for neurodegenerative disorders will exceed $20 billion before the end of the decade, according to a new report.
Global Information announced the availability of four research reports that analyze the global markets for treatments for syndromes of progressive ataxia and weakness disorders. According to GII, the global market for treatments was nearly $14 billion and is expected to reach $23.5 billion by 2017, after increasing at a five-year compound annual growth rate of 9.4%.
Key areas of growth include Friedrich’s ataxia, Gerstmann-Straussler-Scheinker disease, Machado-Joseph disease, progressive bulbar palsy, hereditary spastic paraplegia, hereditary neuropathies, multiple sclerosis and amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease.
Treatments for progressive weakness syndromes — a category that includes MS — are expected to total nearly $14.6 billion this year and $22.8 billion by 2017; MS treatments are expected to reach $19.5 billion by 2017.
Treatments for dementia and movement disorders, such as Parkinson’s disease, are expected to reach $11.1 billion this year and $16.7 billion in 2017.
No comments found
Cardinal’s OncoSourceRx URAC awarded specialty pharmacy accreditation
DUBLIN, Ohio — Cardinal Health Specialty Solutions on Wednesday announced that its specialty pharmacy, OncoSourceRx, has been awarded Specialty Pharmacy Accreditation from URAC, a Washington-based healthcare accrediting organization that establishes quality standards for the healthcare industry.
“We are honored to receive this prestigious accreditation from URAC,” stated Recie Bomar, VP specialty pharmacy for Cardinal Health Specialty Solutions. “We are very pleased to receive this important recognition, which underscores the quality of our work and demonstrates our commitment to complying with national standards for delivering safe and effective specialty pharmacy services.”
“By applying for and receiving Specialty Pharmacy Accreditation, Cardinal Health Specialty Pharmacy, OncoSourceRx, has demonstrated a commitment to quality health care,” added Alan Spielman, URAC president and CEO. “Quality health care is crucial to our nation’s welfare, and it is important to have organizations that are willing to measure themselves against national standards.”
URAC offers the only third-party, voluntary accreditation program of this scope for the pharmacy benefit management and prescription services industries. Its standards were developed by URAC’s Pharmacy Advisory Committee, which includes a range of stakeholders including employers, consumers, pharmacy consultants, health plans, retail pharmacy, pharmacy benefit management organizations, pharmacy professional organizations, labor and large public purchasing groups.
No comments found
CVS/pharmacy, American Diabetes Association sponsor diabetes campaign
WOONSOCKET, R.I. — CVS/pharmacy has announced that it is partnering with the American Diabetes Association as the sponsor of "A Day in the Life of Diabetes" campaign — a photo-sharing campaign on the ADA’s main Facebook page.
The CVS/pharmacy ExtraCare Advantage for Diabetes program will donate $1 to the American Diabetes Association for every photo or image uploaded, up to $25,000. CVS/pharmacy will also co-host a Twitter chat on Nov. 15 with Dr. Elizabeth Seaquist, VP medicine and science for the ADA.
"With 26 million people afflicted with the disease in the U.S. and an additional 79 million Americans at risk for Type 2 diabetes, this chronic condition has reached epic proportions," stated Papatya Tankut, VP pharmacy affairs at CVS Caremark. "By working together with the American Diabetes Association, we’re able to cast a wider net to help more people on their path to better health by sharing educational resources and spreading awareness of programs that can help them to manage diabetes and save money."
Additional activities happening during American Diabetes Month include:
Twitter Chat: To help educate CVS/pharmacy customers about diabetes and how to care for those with diabetes, CVS/pharmacy and the American Diabetes Association will co-host a live Twitter chat on the @CVS_Extra handle, featuring a CVS pharmacist and Seaquist for the ADA via the @AmDiabetesAssn handle. The Twitter chat will take place on Nov. 15, from 3 to 4 p.m. EST. Users that participate in the chat by using the #diabetesmonth or #CVSECAD hashtag, will automatically be entered to win prize packs from the CVS/pharmacy ExtraCare Advantage for Diabetes program.
ExtraCare Advantage for Diabetes Member Drive: The program is free and open to all members of the CVS/pharmacy ExtraCare savings and rewards program; cardholders can sign up at CVS.com/diabetes. Once enrolled, patients and caregivers gain access to:
- $5 coupon for joining’
- Monthly e-newsletter filled with recipes, tips and extra savings; and
- More than $130 in savings from Diabetes Health Magazine available through Dec. 31, 2012.
ExtraCare Advantage for Diabetes members earn ExtraBucks Rewards on more than 100 products used to manage diabetes, including testing supplies, glucose test strips and glucose meters. In addition to exclusive savings, members also have access to a variety of resources including an "Ask Our Pharmacist" section, additional offers, videos and recipes addressing their specific lifestyle needs. Members can log on to CVS.com/ExtraCare or access the CVS mobile app to view the personalized ExtraSavings and ExtraBucks Rewards that are currently available, and choose to "Print" or "Send to Card" their coupon savings and ExtraBucks Rewards.
In addition to earning ExtraBucks Rewards that can be spent on most items in the store, ExtraCare Advantage for Diabetes members receive special offers and discounts on their receipts and at the in-store ExtraCare Coupon Center.
Since its launch in 2010, the CVS/pharmacy ExtraCare Advantage for Diabetes program has helped more than 2 million members save money and better manage the disease.
Actos diabetes drug just received a dangerous black box warning The drug has been linked to Cancer http://spirithappy.org/wp/2011/10/02/type-2-diabetes-diet-actos-linked-to-cancer/